Trial Profile
Tolerability, pharmacokinetic and pharmacodynamic assessment of teriparatide nasal spray versus subcutaneous teriparatide in postmenopausal female volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Nov 2010
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary) ; Teriparatide
- Indications Osteoporosis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 19 Oct 2010 Status changed from recruiting to completed.
- 19 Oct 2010 Results presented at the 32nd Annual Meeting of the American Society for Bone and Mineral Research
- 19 Oct 2010 Study title not official.